Today: 20 May 2026
Caterpillar stock rises as CAT tees up CES 2026 AI keynote, expands Nvidia tie-up

Caterpillar stock rises as CAT tees up CES 2026 AI keynote, expands Nvidia tie-up

New York, Jan 5, 2026, 12:46 EST — Regular session

  • Caterpillar shares climb as the company details an Industrial AI and autonomy showcase at CES 2026
  • CEO Joe Creed to headline a Jan. 7 CES keynote, with Nvidia’s Deepu Talla set to join Caterpillar executives onstage
  • Investors also brace for Friday’s U.S. payrolls report and a late-January earnings window

Caterpillar (CAT.N) shares rose about 2.7% on Monday after the heavy-equipment maker said it will showcase new Industrial AI and autonomy initiatives at CES 2026 and deepen its collaboration with Nvidia (NVDA.O).

The CES spotlight matters because Caterpillar has become a high-conviction industrial bellwether for investors who want exposure to automation, digital services and AI-enabled equipment — themes that can carry more weight when the macro picture turns choppy. Monday’s move came as traders weighed fresh U.S. factory data and the outlook for rates, both key swing factors for capital spending.

Caterpillar said Creed will deliver a keynote in Las Vegas on Wednesday, Jan. 7 at 9:00 a.m. PST, and Nvidia’s vice president of robotics and edge AI, Deepu Talla, will join Caterpillar leaders to announce an expanded collaboration. Caterpillar also plans live demonstrations, including AI-driven features on a Cat 306 mini excavator.

Industrial AI, in plain terms, is using software to turn machine and jobsite data into real-time guidance and safety features. Autonomy means equipment can perform more tasks with less direct human control — a pitch aimed at productivity and labor constraints on worksites.

At 12:46 p.m. EST, Caterpillar was up $16.31 at $614.72, after trading as high as $621.65 earlier in the session. The Industrial Select Sector SPDR ETF (XLI) was up about 1.5%, while the Dow ETF (DIA) gained about 1.6%. Deere (DE.N), a key peer, slipped about 0.6%.

“Technology is accelerating and expanding our ability to meet customer needs,” Creed said in the CES announcement. Caterpillar Investors

The company’s CES push landed on a day when a closely watched gauge of U.S. manufacturing weakened. The Institute for Supply Management’s manufacturing PMI fell to 47.9 in December; readings below 50 signal contraction.

Still, investors have been willing to look past softer factory indicators when they see durable demand tied to data infrastructure and electrification, themes that have helped reframe Caterpillar’s growth profile in recent market commentary.

But the risk case has not gone away: Caterpillar remains exposed to swings in construction and mining activity, and a prolonged downturn in orders can hit dealer inventory moves and pricing power. Trade policy is another uncertainty, with tariffs lifting costs and complicating demand signals, according to recent U.S. manufacturing data and commentary.

Technically, Caterpillar is trading below its 52-week high of $627.50 but well above its 50-day moving average (about $573), leaving the $600 area in focus if momentum cools. The stock’s 52-week range is $267.30 to $627.50.

Next up, traders will watch Creed’s CES keynote on Jan. 7 and Friday’s U.S. jobs report, which the Labor Department has scheduled for 8:30 a.m. ET on Jan. 9. The most immediate company catalyst is the CES keynote itself.

Stock Market Today

  • Entergy's Earnings Growth Masked by Share Dilution, EPS Growth Slower
    May 20, 2026, 12:35 AM EDT. Entergy Corporation (NYSE:ETR) reported strong net income growth, with a 33% rise in the past year and a 57% annualized gain over three years. However, the company increased its shares outstanding by 6.3% over the last twelve months, diluting earnings per share (EPS). Consequently, EPS growth was only 27% last year and 44% annually over three years, indicating slower per-share profitability gains. Market response remained muted as investors focus on EPS rather than total profit, a critical measure of shareholder value. Analysts' forecasts and potential risks to Entergy's business remain important considerations for investors monitoring the stock's long-term performance.

Latest articles

Wall Street Hit by Yield Jolt With Nvidia Up Next

Wall Street Hit by Yield Jolt With Nvidia Up Next

20 May 2026
U.S. stock ETFs remained lower late Tuesday after Wall Street’s main indexes fell for a third straight session, pressured by rising Treasury yields and caution ahead of Nvidia’s earnings. The SPDR S&P 500 ETF dropped 0.7% to $733.73. The 10-year Treasury yield hit 4.687%, its highest since January 2025, before easing. Nvidia shares slipped 0.7% after hours, with traders bracing for a major move post-earnings.
Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

20 May 2026
Viavi Solutions shares dropped 7.1% in after-hours trading Tuesday after the company announced a $500 million public stock offering aimed at repaying debt. The offering, unveiled just after the Nasdaq close, could add roughly 10.1 million new shares. Viavi plans to use proceeds to pay down a $450 million loan. Total debt would fall to $650 million, according to a preliminary SEC filing.
Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

20 May 2026
Analog Devices agreed to acquire Empower Semiconductor for $1.5 billion in cash, sending ADI shares up 1.36% to $419.95 in after-hours trading after closing down 1.02%. The deal, approved by both boards, is expected to close in the second half of 2026 pending regulatory review. Empower CEO Tim Phillips will continue to lead integrated voltage regulator work after the merger.
Lam Research stock jumps 6% as chip-tool rally builds on BofA AI call ahead of CES
Previous Story

Lam Research stock jumps 6% as chip-tool rally builds on BofA AI call ahead of CES

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing
Next Story

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Go toTop